Syndax Pharmaceuticals
- Kelly Wilson
- February 7, 2025
- No Comments
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full…
Iovance Biotherapeutics
- Kelly Wilson
- June 14, 2024
- No Comments
About Iovance Biotherapeutics Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance…
Sumitomo Pharma America, Inc.
- Kelly Wilson
- April 11, 2024
- No Comments
Sumitomo Pharma America (SMPA) is deeply committed to accelerating scientific and therapeutic breakthroughs to support patient-first outcomes in areas of critical need, including psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. SMPA aims to address a wide range of indications where treatment options remain limited or nonexistent. By doing…
Geron
- Kelly Wilson
- March 15, 2024
- No Comments
Geron is a biopharmaceutical company focused on development and commercialization of therapies in hematologic malignancies. Geron aims to deliver on our mission of changing lives by changing the course of blood cancers. Prescribing Information: https://www.geron.com/medicines/ HCP website: www.rytelohcp.com Patient support programs: https://www.rytelohcp.com/patient-support-program Distributor Network and billing and coding guide. https://www.rytelohcp.com/how-to-order Medical Information Hub: 1-855-437-6664 (1-855-GERONMI) To Report Suspected Adverse Reactions…
Eagle Pharmaceuticals
- Kelly Wilson
- February 14, 2024
- No Comments
Eagle is a fully diversified pharmaceutical company working to advance safe and effective treatments for critical care and oncology patients, their care teams, and the overall health system. https://www.eagleus.com/about/
Immunocore, LLC
- Amanda Bridges
- February 27, 2023
- No Comments
Immunocore, LLC is a pioneering, commercial-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infectious and autoimmune diseases.
Genmab
- Amanda Bridges
- February 27, 2023
- No Comments
Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted…
Mirati, (a Bristol Myers Squibb company)
- Amanda Bridges
- January 19, 2023
- No Comments
Oncocyte
- Amanda Bridges
- September 6, 2022
- No Comments
Oncocyte is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.
Sobi, Inc.
- Amanda Bridges
- August 11, 2022
- No Comments
At Sobi North America, we are committed to delivering treatment options for patients with Immune thrombocytopenia (ITP), a rare autoimmune disease affecting platelet production and characterized by fatigue, bruising and bleeding. Today, there is increased awareness of the available treatment options, and better life may be possible for people living with ITP.Our portfolio also addresses…
PharmaEssentiaTM
- Amanda Bridges
- July 6, 2022
- No Comments
PharmaEssentia Corporation, based in Taipei, Taiwan, is a rapidly growing biopharmaceutical innovator. Leveraging deep expertise and proven scientific principles, the company aims to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one approved product and a diversifying pipeline. Founded in 2003, the company is now expanding its global…
Aveo Oncology, an LG Chem company
- Amanda Bridges
- May 2, 2022
- No Comments
About Us AVEO Oncology (“AVEO”) is an oncology-focused biopharmaceutical company committed to providing innovative solutions to improve cancer patients’ lives. On January 20, 2023, AVEO was acquired by LG Chem, Ltd. (“LG Chem”), establishing a U.S. commercial presence for LG Chem and expanding LG Chem’s global oncology portfolio. AVEO continues to commercialize FOTIVDA® (tivozanib) in…
HUTCHMED
- Amanda Bridges
- April 8, 2022
- No Comments
HUTCHMED is an innovative, global, biopharmaceutical company committed to the discovery and development of targeted oncology therapies, inclusive of neuroendocrine tumors.
ADC Therapeutics
- Amanda Bridges
- July 13, 2021
- No Comments
ADC Therapeutics. Confronting cancer with the full potential of our science. ADC Therapeutics is a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation, targeted antibody drug conjugates (ADCs. ADC Therapeutics is advancing its proprietary PBD-based ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Visit…
TG Therapeutics
- Amanda Bridges
- June 17, 2021
- No Comments
We believe that the best solution for patients may not lie in a single drug but in a unique combination of medicines. TG Therapeutics was founded with one goal in mind—to leverage scientific advances in B-cell biology to develop novel treatments for patients. We’ve dedicated ourselves to this simple concept and to the study of…
Caris Life Sciences
- Amanda Bridges
- May 12, 2021
- No Comments
Caris Life Sciences® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. MI Exome™…
Regeneron
- Amanda Bridges
- March 25, 2021
- No Comments
LIBTAYO Surround Product Website CSCC Study Results CSCC Patient Examples Patient Resources
Apellis Pharmaceuticals, Inc.
- Amanda Bridges
- January 25, 2021
- No Comments
We Are Apellis We understand that living with a serious disease–like PNH–can pose many challenges and needs that can remain unaddressed. As leaders in developing targeted C3 therapies, we aim to address these needs by leveraging courageous science, creativity, and compassion to develop transformative therapies for a broad range of debilitating diseases that are driven…
Blue Earth Diagnostics, Inc.
- Katrina Williams
- January 8, 2021
- No Comments
Blue Earth Diagnostics, a subsidiary of Bracco Imaging S.p.A., is a recognized leader in the development and commercialization of novel PET radiopharmaceuticals to inform clinical management and guide care for cancer patients in areas of unmet medical need. Formed in 2014, Blue Earth Diagnostics is led by proven experts in nuclear medicine, who have expanded…
Oncopeptides
- Amanda Bridges
- November 17, 2020
- No Comments
About Oncopeptides Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. In 2000, the Company was formed by some of Sweden’s most leading scientists with ties preeminent oncology research institutions. Oncopeptides’ headquarters is in Stockholm, Sweden with a U.S. headquarters in Boston, Massachusetts. In addition to Boston, Oncopeptides…
Jazz Pharmaceuticals plc
- Amanda Bridges
- October 6, 2020
- No Comments
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from…
Gilead
- Amanda Bridges
- September 25, 2020
- No Comments
Gilead, is a leader in next generation antibody-drug conjugate (ADC) technology, committed to helping people with hard-to-treat cancers. The impossible is simply what hasn’t been achieved yet. Gilead’s research and development program is focused on what’s next. Their goal is to discover, identify and evaluate investigational compounds that show potential to advance the treatment of…
Blueprint Medicines
- Katrina Williams
- June 18, 2020
- No Comments
About Blueprint Medicines Blueprint Medicines is a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer immunotherapy, we are developing transformational medicines rooted in our leading expertise in protein kinases, which are proven drivers of disease. Our uniquely targeted, scalable approach empowers the rapid design and…
Deciphera Pharmaceuticals
- Katrina Williams
- May 20, 2020
- No Comments
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform…
Karyopharm Therapeutics
- Amanda Bridges
- April 10, 2020
- No Comments
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm’s Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the…
Epizyme
- Amanda Bridges
- April 9, 2020
- No Comments
Epizyme’s vision is to rewrite treatment for cancer and other serious diseases through novel epigenetic medicines. Epizyme aspires to change the standard of care for patients and physicians by developing medicines with fundamentally new mechanisms of action. Learn more Epizyme.com. Patient Assistance & Product Support: EpizymeNOW 1-833-4EPI(NOW) (437-4669)
Daiichi Sankyo, Inc.
- Amanda Bridges
- March 19, 2020
- No Comments
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies…
MorphoSys US
- Katrina Williams
- March 12, 2020
- No Comments
MorphoSys is a clinical stage biopharmaceutical company headquartered in Munich, Germany. MorphoSys is dedicated to the discovery, development and commercialization of exceptional, innovative therapies for patients suffering from serious diseases. The focus is on cancer. Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys, together with its partners, has developed and contributed…
BeOne Medicines US
- Katrina Williams
- November 13, 2019
- No Comments
Website: https://beonemedicines.us/ Patient Support: https://www.mybeonesupport.com/
Natera
- Katrina Williams
- September 4, 2019
- No Comments
Natera has developed Signatera, a personalized ctDNA test for molecular residual disease (MRD) detection and recurrence monitoring in patients previously diagnosed with cancer. Signatera’s tumor-informed assay is optimized to detect low levels of ctDNA, with high accuracy in identifying MRD and recurrence with longer lead times. Signatera has been clinically validated in multiple cancer types…
Recordati Rare Diseases Inc.
- Katrina Williams
- April 8, 2019
- No Comments
Rare diseases aren’t just in our name: they are at the core of all that we do. We work side-by-side with rare disease communities to raise awareness, educate, and advocate for improved diagnosis. Together, we can celebrate our successes and strengthen our impact for people living with rare diseases. Learn More: https://sylvant.com/understanding-imcd/what-is-imcd/ Learn More:…
Stemline Therapeutics
- Katrina Williams
- February 6, 2019
- No Comments
Company Overview Stemline Therapeutics, Inc. (“Stemline”) a wholly-owned subsidiary of the Menarini Group, is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. Our dedicated team of scientists, specialists, researchers, and developers are committed to providing transformational oncology treatments to those who need it, with the ultimate goal of improving…
Coherus Biosciences
- Katrina Williams
- February 6, 2019
- No Comments
Coherus is focused on developing and commercializing a diversified portfolio of immuno-oncology therapies. The advancement of multiple clinical stage candidates underscores our commitment to immuno-oncology treatments while the biosimilar business enables us to provide better access to therapy for patients with life-altering illnesses. About Coherus Solutions™ Coherus is committed to supporting patients with reimbursement and…
Verastem Oncology
- Amanda Bridges
- October 8, 2018
- No Comments
Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. We are driven by the strength, tenacity and courage of those battling cancer – single-minded in our resolve to deliver new therapies that not only keep cancer at bay, but…
Rigel Pharmaceuticals
- Amanda Bridges
- September 24, 2018
- No Comments
Rigel Pharmaceuticals, Inc. is a South San Francisco-based biopharmaceutical company focused on discovering, developing, and providing novel therapies that enhance the lives of people with immune and hematological disorders, cancers, and rare diseases. Rigel’s clinical development programs span multiple disease targets including chronic immune thrombocytopenia, autoimmune hemolytic anemia and others. Rigel’s first FDA approved product…
Agios Pharmaceuticals
- Amanda Bridges
- April 12, 2018
- No Comments
Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has an approved oncology precision medicine and multiple first-in-class investigational therapies in clinical and/or preclinical…
Puma Biotechnology, Inc.
- Amanda Bridges
- November 28, 2017
- No Comments
Puma Biotechnology focus is on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
Novocure
- Amanda Bridges
- August 2, 2017
- No Comments
Novocure is an oncology company developing a profoundly different cancer treatment utilizing a proprietary therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product, Optune® – the TTFields delivery system for glioblastoma (GBM) – was launched in the U.S. for the treatment of recurrent…
EMD Serono
- Amanda Bridges
- March 22, 2017
- No Comments
EMD Serono is a science-led organization of curious minds dedicated to delivering transformative medicines that can make a difference in the lives of people affected by cancer. We apply our scientific curiosity to tackling challenging tumor types in key areas—gastrointestinal (GI), genitourinary (GU), and thoracic cancers—where there are unmet needs and where we believe we…
Guardant Health
- Amanda Bridges
- March 22, 2017
- No Comments
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Click here to listen to Dr. Santos, FLASCO Secretary, discuss the role of liquid biopsy in NSCLC. Dr. Santos shares his experience using Guardant360 in clinical practice, including his perspective…
Adaptive Biotechnologies®
- Amanda Bridges
- March 16, 2017
- No Comments
Adaptive Biotechnologies Company Description Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the…
Kite, a Gilead Company
- Amanda Bridges
- March 8, 2017
- No Comments
Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, focused on cell therapy to treat and potentially cure cancer. As the global cell therapy leader, Kite has treated more patients with CAR T-cell therapy than any other company. Kite has the largest in-house cell therapy manufacturing network in the world,…
Exelixis, Inc.
- Amanda Bridges
- June 7, 2016
- No Comments
Founded in 1994, Exelixis is a biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines. Visit our website to learn more. https://www.exelixis.com.
Biotheranostics, a Hologic Company
- Amanda Bridges
- May 12, 2016
- No Comments
Biotheranostics, Inc. represents the oncology portfolio within the Diagnostic Solutions division of Hologic, Inc. The CLIA certified, CAP accredited laboratory provides two proprietary, highly differentiated molecular diagnostic tests for breast and metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID, respectively. Breast Cancer Index (BCI) Breast Cancer Index (BCI) is the only genomic test recognized…
AbbVie
- Amanda Bridges
- March 31, 2016
- No Comments
At AbbVie, we strive to discover and develop medicines that deliver transformational improvements in cancer treatment by uniquely combining our deep knowledge in core areas of biology with cutting-edge technologies, and by working together with our partners – scientists, clinical experts, industry peers, advocates, and patients. We remain focused on delivering these transformative advances in…
Heron Therapeutics
- Amanda Bridges
- March 11, 2016
- No Comments
At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents. Our goal is to build on therapeutics with well-known pharmacology by improving their safety and efficacy as well…
Clovis Oncology, Inc.
- Amanda Bridges
- September 28, 2015
- No Comments
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our development programs are targeted at specific subsets of cancer, combining personalized medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.
Incyte Corporation
- Amanda Bridges
- July 16, 2015
- No Comments
OVERVIEW Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines. Since 2002 Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value…
Pharmacyclics
- Amanda Bridges
- July 16, 2015
- No Comments
For more information about Pharmacyclics LLC, an AbbVie Company, please visit pharmacyclics.com.
Novartis
- Amanda Bridges
- July 16, 2015
- No Comments
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products…
Sandoz, a Novartis Division
- Amanda Bridges
- July 16, 2015
- No Comments
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. With our leading-edge processes in manufacturing, strong pipeline of treatments and reliable supply, we strive to improve patient access to more affordable,…
Taiho Oncology
- April 26, 2015
- No Comments
Taiho Oncology, Inc., a division of Taiho Pharmaceutical Co., Ltd. and Otsuka Holdings Co., Ltd., has built a world class clinical development organization that works urgently to develop innovative cancer treatments. Taiho has an oral oncology pipeline consisting of both novel antimetabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the…
Cencora Specialty GPOs & Oncology Supply
- April 26, 2015
- No Comments
Cencora, formerly AmerisourceBergen, empowers oncology physician practices and ensures their patients have access to the most innovative and cost-effective specialty care close to home. Through our ION Oncology Specialty GPO Network and Oncology Supply specialty distribution, along with our portfolio of integrated Specialty Solutions, we are a unified team of specialty practice partners, committed to…
Sanofi
- April 24, 2015
- No Comments
Overview Sanofi’s focus on patients has driven our historical and ongoing strategy to create long-term value by researching and delivering innovative treatments. Sanofi Oncology’s heritage in oncology has given us an extensive knowledgebase that enriches our current research expertise. This experience encompasses a wide variety of cancer types, disease stages, patient populations, and patient needs….
GSK Oncology
- April 23, 2015
- No Comments
GSK Oncology’s mission and purpose is to deliver potentially transformative medicines and industry-leading programs that provide enduring impact and hope for our patients and their loved ones. For more information, please visit Together With GSK Oncology Get an inside look at ZEJULA and browse our collection of videos to learn how it may help appropriate…
AstraZeneca
- FLASCO
- March 25, 2015
- No Comments
Company Overview Patient Assistance Programs Overview AstraZeneca has a deep-rooted heritage in Oncology and offers a quickly-growing portfolio of new medicines that has the potential to transform patients’ lives and the Company’s future. With at least six new medicines to be launched between 2014 and 2020, and a broad pipeline of small molecules and biologics…
Acrotech Biopharma
- FLASCO
- March 25, 2015
- No Comments
The STAR (Spectrum Therapy Access Resources) Co-pay Program will provide the following co-pay assistance to eligible patients, across the Spectrum portfolio: First Date of Service: Patient will have a $0 patient out of pocket. STAR will cover 100% of the co-insurance/ cost share for the Spectrum product. Subsequent Dates of Service: Patient will be responsible…
IPSEN BioPharmaceuticals, Inc.
- FLASCO
- March 25, 2015
- No Comments
Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we focus our resources, investments and energy on discovering, developing and commercializing medicines in three key therapeutic areas – Oncology, Rare Disease and Neuroscience. We are dedicated to providing hope for patients whose lives are challenged by unmet medical needs. Our…
Pfizer Oncology
- FLASCO
- March 25, 2015
- No Comments
Overview At Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes three core mechanisms of action to attack cancer from multiple angles, including small molecules, antibody-drug conjugates (ADCs), and bispecific antibodies, including other immune-oncology biologics. We are focused on delivering transformative therapies in…
Foundation Medicine
- Amanda Bridges
- February 20, 2015
- No Comments
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and…
Celgene
- Amanda Bridges
- February 20, 2015
- No Comments
Company Overview Patient Assistance Programs Contact Info Overview COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE Celgene seeks to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the…
Bayer
- Amanda Bridges
- February 20, 2015
- No Comments
Products, People and Programs Making a Difference For over 150 years Bayer has been an innovation company rooted in science. Our presence in the U.S. harkens back to the mid-19th century as a chemical company making dyes in Albany, NY. However, by the late-19th century we moved into the healthcare field with the introduction of…
Biodesix
- Amanda Bridges
- February 12, 2015
- No Comments
Biodesix was founded in 2005 to apply the principles of complex data analysis and mass spectrometry (MS) to the discovery and development of improved multivariate tests that give physicians better information to understand the patient and their disease. Understanding the clinically meaningful information contained within each patient’s molecular profile may improve diagnosis and therapeutic intervention…
Helsinn Therapeutics
- Amanda Bridges
- February 12, 2015
- No Comments
Helsinn is a privately owned pharmaceutical group headquartered in Lugano, Switzerland, with operating subsidiaries in Ireland, the U.S. and an office in China. Helsinn is one of the world’s leading supportive cancer care companies. Our vision is to help people with cancer get the most of every day. We make everything we do, from the…
Merck
- Amanda Bridges
- February 11, 2015
- No Comments
Overview Merck Vision Is to make a difference in the lives of people globally through their innovative medicines, vaccines, biologic therapies, consumer care and animal health products. They aspire to be the best healthcare company in the world and are dedicated to providing leading innovations and solutions for tomorrow. Merck Mission Is to discover, develop and provide…
Johnson & Johnson
- Amanda Bridges
- February 9, 2015
- No Comments
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare…
Boehringer Ingelheim
- Amanda Bridges
- January 13, 2015
- No Comments
Boehringer Ingelheim in Oncology Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim Oncology, we are giving patients new hope, by taking cancer on. We are dedicated to collaborating with the oncology community on a shared journey to deliver leading science. Our primary focus is in lung and gastrointestinal cancers, with the…
Takeda Oncology
- Amanda Bridges
- January 13, 2015
- No Comments
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. Our leadership in oncology extends more than 25 years and includes a range of therapies that have helped to transform the treatment landscape for previously underserved patient populations, in some cases shifting paradigms and becoming standard of care. We…
Genentech
- Amanda Bridges
- January 13, 2015
- No Comments
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit www.gene.com. About Genentech in…
Bristol Myers Squibb
- Amanda Bridges
- January 13, 2015
- No Comments
Bristol Myers Squibb is committed to discovering, developing and delivering innovative medicines for the treatment of cancer. Our pipeline in oncology is robust, with several experimental anticancer compounds in development. It is also diverse, reflecting a range of modalities and research programs. One such area is immuno-oncology. Immuno-oncology represents an innovative approach to cancer research…
Astellas Pharma
- Amanda Bridges
- January 13, 2015
- No Comments
Astellas Oncology is committed to elevating the standard of cancer care. We focus on developing innovative, targeted therapies for hard-to-treat cancers with limited treatment options, which is where we see the greatest opportunity to help people living with cancer. Visit www.AstellasOncology.com. Reimbursement Hotline Local Account Manager: Donna Duany, Access & Reimbursement Manager, Health Systems Tel:…
